ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 83 filers reported holding ALLOVIR INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,941 | -25.9% | 70,670 | +17.2% | 0.00% | – |
| Q2 2023 | $205,054 | +17.0% | 60,310 | +35.5% | 0.00% | – |
| Q1 2023 | $175,330 | -12.4% | 44,500 | +14.1% | 0.00% | – |
| Q4 2022 | $200,070 | -11.1% | 39,000 | +36.8% | 0.00% | – |
| Q3 2022 | $225,000 | +114.3% | 28,500 | +6.3% | 0.00% | – |
| Q2 2022 | $105,000 | -30.5% | 26,800 | +20.2% | 0.00% | – |
| Q1 2022 | $151,000 | -47.8% | 22,300 | 0.0% | 0.00% | – |
| Q4 2021 | $289,000 | -79.6% | 22,300 | -60.5% | 0.00% | -100.0% |
| Q3 2021 | $1,414,000 | -94.6% | 56,440 | -95.8% | 0.00% | -90.9% |
| Q2 2021 | $26,336,000 | +2.3% | 1,334,129 | +21.3% | 0.01% | 0.0% |
| Q1 2021 | $25,735,000 | -34.5% | 1,099,800 | +7.7% | 0.01% | -42.1% |
| Q4 2020 | $39,271,000 | +49.0% | 1,021,611 | +6.6% | 0.02% | +35.7% |
| Q3 2020 | $26,365,000 | – | 958,743 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $28,611 | 1.60% |
| GMT CAPITAL CORP | 2,758,846 | $14,152,880 | 0.65% |
| SVB FINANCIAL GROUP | 43,019 | $220,687 | 0.60% |
| Regency Capital Management Inc.\DE | 75,025 | $384,878 | 0.44% |
| Redmile Group, LLC | 1,907,969 | $9,787,881 | 0.40% |
| Samsara BioCapital, LLC | 82,336 | $422,384 | 0.09% |
| Alkeon Capital Management | 4,605,104 | $23,624,184 | 0.09% |
| Woodline Partners LP | 1,087,090 | $5,576,772 | 0.08% |
| XTX Topco Ltd | 53,422 | $274,055 | 0.06% |
| Virtus ETF Advisers LLC | 20,906 | $107,248 | 0.06% |